KRAS and endometriosis: A systematic review and meta-analysis
Systematic review / meta-analysis
OA: gold
public-domain-us
Abstract
BackgroundEndometriosis is a chronic gynecological condition affecting approximately 10% of women of reproductive age worldwide. Accumulating molecular evidence suggests that endometriotic lesions harbor somatic oncogenic mutations, including activating mutations in the KRAS gene. However, the prevalence of KRAS mutations across endometriosis subtypes and their clinical significance remain poorly defined.ObjectivesThis systematic review and meta-analysis aimed to estimate the prevalence of somatic KRAS mutations in endometriosis, characterize variant allele frequencies, and evaluate associations with clinical outcomes, including recurrence, infertility, and malignant transformation.MethodsA comprehensive search of PubMed/MEDLINE, Embase, and Web of Science/Scopus was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines (International Prospective Register of Systematic Reviews: CRD420261303629). Eligible studies included observational designs and molecular sequencing reports on endometriotic tissue. Pooled prevalence was estimated using a random-effects meta-analysis (DerSimonian-Laird model), with heterogeneity assessed using Cochran's Q and I2 statistics.ResultsSeven studies were included, covering deep infiltrating, ovarian, and superficial peritoneal endometriosis subtypes. The pooled KRAS mutation prevalence was 48% (95% confidence interval: 38%-58%), with substantial heterogeneity (I2 = 77%). Mutations were most frequent in deep infiltrating and ovarian lesions (50%-55%) compared with that in superficial peritoneal disease (∼30%-35%). Variant allele fractions were consistently low (<20%), reflecting clonal epithelial expansion. KRAS-positive patients demonstrated greater disease extent and surgical complexity, though associations with pain, infertility, and recurrence were not statistically significant.ConclusionPreliminary evidence suggests that KRAS mutations are common in endometriosis; however, findings should be interpreted cautiously owing to substantial study heterogeneity and limited available data. KRAS may hold biological significance as a biomarker; however, current evidence is insufficient to support routine clinical use.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (25)
- ARID1A mutations in endometriosis-associated ovarian carcinomas via openalex
- Biological significance of KRAS mutant allele expression in ovarian endometriosis via openalex
- Cancer-associated mutations in endometriosis: shedding light on the pathogenesis and pathophysiology via openalex
- Cancer-Associated Mutations in Endometriosis without Cancer via openalex
- Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium via openalex
- Endometrial carcinoma of the ovary arising in endometrial tissue in that organ via openalex
- Endometriosis via openalex
- Endometriosis-Associated Ovarian Cancer: The Origin and Targeted Therapy via openalex
- Iatrogenic endometriosis harbors somatic cancer-driver mutations via openalex
- KRAS Mutation in Endometriosis-Associated Ovarian Borderline and Malignant Epithelial Tumors via openalex
- KRAS mutations and endometriosis burden of disease via openalex
- KRAS mutations in ovarian low-grade endometrioid adenocarcinoma: association with concurrent endometriosis via openalex
- Molecular analysis suggests oligoclonality and metastasis of endometriosis lesions across anatomically defined subtypes via openalex
- Oncogenic mutations in histologically normal endometrium: the new normal? via openalex
- Positive correlation between Bax and Bcl-2 gene polymorphisms with the risk of endometriosis: A case-control study via openalex
- The management of menopause in women with a history of endometriosis: a systematic review via openalex
- The role of somatic mutations in endometriosis: pathogenesis, progression, and fibrogenesis (narrative review) via openalex
- Women with endometriosis in the United States: National Survey of Family Growth, 2011–2019 via openalex
- W4211081176 via openalex
- W2810127666 via openalex
- W2107328434 via openalex
- W1979423827 via openalex
- W2468996569 via openalex
- W4234160457 via openalex
- W4414151040 via openalex
Source provenance
- europepmc
- last seen: 2026-11-18T06:10:28.346261+00:00
- openalex
- last seen: 2026-11-18T06:02:33.299327+00:00
- pubmed
- last seen: 2026-11-18T06:04:25.516603+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine